Compare Immunovant Inc. Common Stock (IMVT) vs Pan American Silver Corp. Common Stock (PAAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Pan American Silver Corp. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B), while Pan American Silver Corp. Common Stock trades at $46.32 (market cap $18.72B). The key difference: Pan American Silver Corp. Common Stock is far larger — about 3× Immunovant Inc. Common Stock's market cap, and Pan American Silver Corp. Common Stock pays a 1.62% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and Pan American Silver Corp. Common Stock for 1 Days on average.
| IMVT | PAAS | |
|---|---|---|
Market Cap | $6.25B | $18.72B |
Volume | 1,755,411 | 2,957,838 |
Sector | Health | Basic Materials |
52-Week High | $44.96 | $68.70 |
52-Week Low | $17.03 | $33.20 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.35B | $17.86B |
Dividend Yield | — | 1.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Pan American Silver Corp. Common Stock
Pan American Silver is a mining company focused on silver and gold production in the Americas. It also explores and develops precious metals properties.
Read more on PAAS →
